H.C. Wainwright Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $9.5
A. G. P. Maintains Myomo(MYO.US) With Buy Rating, Maintains Target Price $6.75
Craig-Hallum Maintains Myomo(MYO.US) With Buy Rating, Announces Target Price $10
Craig-Hallum Maintains Buy on Myomo, Lowers Price Target to $10
Myomo Analyst Ratings
12 Health Care Stocks Moving In Thursday's Intraday Session
Express News | Myomo Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results
Craig-Hallum Sticks to Their Buy Rating for Myomo (MYO)
Myomo Sees FY Rev $50M-$53M >MYO
Myomo Continues to Expect Rev Growth to Accelerate in 2H
Myomo Q1 EPS $(0.80) Misses $(0.06) Estimate, Sales $9.83M Miss $10.91M Estimate
Myomo 1Q Loss/Shr 8c >MYO
Press Release: Myomo Reports First Quarter 2025 Financial and Operating Results
Express News | Myomo Q1 Gross Margin 67.2%
Express News | Myomo Q1 Operating Expenses USD 10.1 Million
Express News | Myomo Q1 Operating Income USD -3.5 Million
Myomo | 10-Q: Q1 2025 Earnings Report
Myomo | 8-K: Myomo Reports First Quarter 2025 Financial and Operating Results
A Glimpse of Myomo's Earnings Potential
Craig-Hallum Maintains Myomo(MYO.US) With Buy Rating